05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
As is the case in most merger transactions, both the buyer and seller retain their own counsel. Gene...
Read More >
In this five-part podcast series, we consider some of the basic questions around monitors and monito...
Read More >
POWER INTEGRATIONS, INC v. SEMICONDUCTOR COMPONENTS - Before Prost, Reyna, and Stoll. Appeal from ...
Read More >
In Project Surveillance, Inc. v. The Travelers Indemnity Company, No. 4:19-CV-03324, 2020 WL 292247 ...
Read More >
On the heels of the U.S. Women’s Soccer Team’s World Cup win, Governor Andrew Cuomo on July 10, 20...
Read More >
The Commodity Futures Trading Commission (“CFTC”) recently released its statutorily mandated 2019 ...
Read More >